CClinicalTrials.gg
CompletedNCT03736746Updated Apr 25, 2022

Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals

An interventional study of Motivational Interviewing in Other Cancer, sponsored by Dana-Farber Cancer Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-25.

Sponsored by Dana-Farber Cancer Institute · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This research study is evaluating the acceptability and feasibility of using a cognitive behavioral intervention called Motivational Interviewing to help persons with pain from cancer set goals for managing that pain.

Read the detailed description

This study is being conducted to evaluate a new way that clinicians can help identify the goals that cancer participants have for managing their pain. This new method uses discussion between a patient and a clinician, in this case a registered nurse, during which one or more goals may be set. At this time, there are no tested methods that clinicians can use for helping patients set these kinds of goals.

02

Conditions studied

  • Other Cancer

Browse trials for

Keywords

  • Other Cancer
03

In context

Cancer Pain

338 studies on the registry are indexed under Cancer Pain; 71 are open to participants now.

This study's enrollment of 54 is close to the median of 60 across 254 interventional studies indexed under Cancer Pain.

Browse Cancer Pain studies →

Lead sponsor

Dana-Farber Cancer Institute is the lead sponsor of 813 studies on the registry; 124 are open to participants now.

Of its 113 completed or terminated interventional studies of FDA-regulated products, 77 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • At least 18-years of age
  • Has an appointment with DFCI ambulatory palliative care service for cancer-related pain
  • Can speak English

Exclusion criteria

Exclusion Criteria:

-Diagnosis of delirium or other cognitive impairment

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Motivational Interviewing

    * Will entail two-to-four Motivational Interviewing sessions per participant * Will include a battery of questionnaires * Investigator-led discussion about the participant's pain experience which is focused on the participant reporting of functional pain goals (FPGs). * The investigator will elicit questions and goals that participants will be encouraged to discuss with their palliative care providers

    Behavioral: Motivational Interviewing

Interventions

  • BehavioralMotivational Interviewing

    An investigator-led discussion about the participant's pain experience which is focused on the participant reporting of functional pain goals (FPGs)

06

What researchers measure

Primary outcomes

  1. Feasibility of Motivational Interviewing intervention

    The proportion of enrolled participants completing at least one follow-up Motivational Interviewing session (at least two sessions total). The proportion of participants completing at least one follow-up intervention session will be estimated along with an exact 90% confidence interval.

    Time frame: 1 year

Secondary outcomes

  1. Motivational Interviewing intervention usage rate

    The number of interventions sessions attended divided by the total possible number of interventions sessions reported as the sample mean.

    Time frame: 1 year

  2. Participant intervention acceptability

    The Participant Experience Questionnaire, developed by the investigator, will be used to summarize overall patient-reported acceptability in this study. Summary measures of median/range and mean/SD for total categorical scores, the time in weeks from the initial to follow-up intervention visit, and the number of completed intervention sessions will be reported.

    Time frame: 1 year

  3. Attitudinal barriers to pain

    Attitudinal barriers to pain management will be measured using the Barriers Questionnaire-II which measures four attitudinal realms with 27 self-rated questions about pain beliefs. The total score will be calculated at study entry and after the first follow-up visit and scores will be summarized (median/range, mean/SD). If additional sessions are completed, the scores will be plotted over time and trends will be explored with graphical methods.

    Time frame: 1 year

  4. Pain Self-Efficacy

    Pain self-efficacy will be measured using the Pain Self-Efficacy Questionnaire in which participants rate their confidence in daily living activities despite pain using a Likert-type scale.The total score will be calculated at study entry and after the first follow-up visit and scores will be summarized (median/range, mean/SD). If additional sessions are completed, the scores will be plotted over time and trends will be explored with graphical methods.

    Time frame: 1 year

  5. Observed engagement in goals-setting

    Observed engagement will be evaluated using the instrument developed by the investigator for this study in which discussions of behaviors indicating active goal setting will be tabulated and salient quotes will be extracted for dissemination. Categories are: 1. pain as an obstacle 2. what helped pain before 3. life with controlled pain 4. suggestions to control pain 5. suggestions actually used 6. help-seeking

    Time frame: 1 year

  6. Motivational Interviewing intervention fidelity

    Fidelity to Motivational Interviewing methods will be assessed on 33% of interviews using the Motivational Interviewing Skills for Health Care Encounters which is used to evaluate the degree to which the person providing the intervention follows five domains key to Motivational Interviewing.The domains are: 1. Motivational Interviewing philosophy 2. health interviewing 3. motivation 4. Motivational Interviewing principles 5. interpersonal process Each domain has specific behaviors that are rated as: 1. deficient 2. developing 3. accomplished 4. not applicable

    Time frame: 1 year

07

Study locations

1 site
  • Dana Farber Cancer Institute
    Boston, Massachusetts 02215, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Feb 9, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03736746
Lead sponsor
Dana-Farber Cancer Institute
Collaborators
Sigma Theta Tau International Honor Society of Nursing
Responsible party
Olga Ehrlich (Principal Investigator, Dana-Farber Cancer Institute) — Principal investigator
First posted
Nov 9, 2018
Start date
Nov 16, 2018
Primary completion
Aug 2, 2019
Completion
Aug 2, 2019
Last update
Apr 25, 2022

Study contacts

Olga Ehrlich, PhD
principal investigator · Dana-Farber Cancer Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion